Fundraising Fox

AMPLY Discovery

Techstars '23

Belfast, GB · 4 known investors

amplydiscovery.com ↗

AMPLY Discovery is a UK-based biotech company that uses AI and computational biology to identify therapeutic targets in non-coding regions of the genome and develop first-in-class drugs through an integrated discovery platform combining machine learning with wet-lab validation. The company is developing therapeutics for oncology and drug-resistant infectious diseases, particularly antimicrobial-peptide and long non-coding RNA oligonucleotide programmes.

AI & Machine LearningBiotechDeep TechHealthtechin /amply-discovery

Founders & leadership

OR
Oliver RauschinCSO

Investors · 4

Clarendon Fund Managers Ltd.Belfast · $25K – $3.9M
TechstarsBoulder · $220K
Twin Path VenturesLondon · $952.5K
QUBISreportedBelfast · $12.7K – $127K

Companies House · registry record

View on Companies House ↗
Registered name
AMPLY DISCOVERY LIMITED
Company number
NI676691
Status
Active
Company type
Private limited company
Incorporated
19 Feb 2021
Registered office
C/O Qubis Ltd, 63 University Road, Belfast, BT7 1NF
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Accounts
last made up to 28 Feb 2026 · next due 30 Nov 2027
Confirmation statement
last made up to 6 Mar 2026 · next due 20 Mar 2027

Current officers · 5

  • Mark Granville Beards — director, appointed 24 Feb 2023
  • Christopher James Creevey — director, appointed 19 Feb 2021
  • Anne Elizabeth Dornan — director, appointed 19 Feb 2021
  • Benjamin James Thomas — director, appointed 19 Feb 2021
  • Dermot Tierney — director, appointed 19 Feb 2021

Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news